Synthetic Cartilage Implant

The Cartiva SCI is a novel osteochondral defect repair implant with properties similar to those of cartilage, designed for the treatment of first metatarsophalangeal joint osteoarthritis.

Setting a new standard for treating hallux rididus

  • First new articular surface material approved by FDA in 18 years.1

  • The only FDA approved cartilage-like polymer.

  • Proven effective in the largest, longest multi-center trial ever conducted for first MTP OA.2

  • Study data evaluated as low risk of bias in comprehensive published review.3

  • Awarded the Roger A. Mann Award twice (2015 & 2017), for the best clinical research in foot and ankle.2,4

Related categories